|
Session Title |
Talk Title |
View |
Curriculum Ref |
5541 |
Sir Thomas Lewis Keynote Lecture |
Prediction and prevention of sudden cardiac death in the young |
|
|
5307 |
Opening Ceremony |
Big data: a big deal for cardiology? |
|
|
7033 |
Pericardial disease: imaging and therapy |
Acute pericarditis/myocarditis |
|
|
7034 |
Pericardial disease: imaging and therapy |
Constriction |
|
|
7035 |
Pericardial disease: imaging and therapy |
Management of pericardial effusion |
|
|
5384 |
ECG Interpretation with Simon Fynn and Edward Rowland |
|
|
|
5385 |
ECG Interpretation with Simon Fynn and Edward Rowland |
|
|
|
7157 |
SAC session |
Training in Heart Failure in 2016 (10 mins + 5 mins for discussion) |
|
|
7159 |
SAC session |
|
|
|
5677 |
SAC session |
Simulation Training in Cardiology (10mins + 5 mins for discussion) |
|
|
6995 |
MDT-Live: cardiac assessment prior to non-cardiac surgery |
Case presenter |
|
|
5706 |
Percutaneous management of structural heart disease |
Alcoholic Septal Reduction? Is this too simple a solution to a complex disease |
|
|
5803 |
Percutaneous management of structural heart disease |
Where next? |
|
|
5398 |
Percutaneous management of structural heart disease |
Will TAVI supplant surgical AVR over the next 5 years? |
|
|
5399 |
Percutaneous management of structural heart disease |
A giant step backwards? Balloon valvuloplasty puts a TOE forwards |
|
|
5404 |
Myocardial infarction management in 2016 |
Raised troponin: so what? |
|
|
5804 |
Myocardial infarction management in 2016 |
55 years old, STEMI, pulmonary oedema - should I wait or should I go now? |
|
|
7248 |
Myocardial infarction management in 2016 |
CULPRIT and PRAMI. So you saw the trials: did it change your practice? |
|
|
7296 |
Modern management of syncope |
Treatment options for syncope |
|
|
5410 |
Modern management of syncope |
An overview of syncope: syndromes within syndromes? |
|
|
7761 |
Modern management of syncope |
How to set up and run a syncope service |
|
|
5417 |
New approaches to heart failure therapy |
Role of ventilatory therapies in patients with heart failure |
|
|
5418 |
New approaches to heart failure therapy |
Autonomic modulation for heart failure |
|
|
5419 |
New approaches to heart failure therapy |
New pharmacological approaches |
|
|
5424 |
Genetic syndromes in ACHD: diagnoses not to miss |
22Q11 |
|
|
5425 |
Genetic syndromes in ACHD: diagnoses not to miss |
Loeys Dietz |
|
|
5426 |
Genetic syndromes in ACHD: diagnoses not to miss |
Noonan |
|
|
6975 |
Genetic syndromes in ACHD: diagnoses not to miss |
Holt Oram |
|
|
6976 |
Genetic syndromes in ACHD: diagnoses not to miss |
Turner |
|
|
7587 |
Clinical study groups, clinical trials and the BHF |
The role of the NCRI in the design and running of clinical cancer trials in the UK |
|
|
7697 |
Clinical study groups, clinical trials and the BHF |
The role of cardiovascular clinical study groups in the evaluation of treatments for uncommon cardiac conditions |
|
|
7699 |
Clinical study groups, clinical trials and the BHF |
Potential impact of clinical trials in the UK on the management of coronary artery disease |
|
|
7082 |
Interventional cardiology |
|
|
|
7100 |
ESC guidelines on ventricular arrhythmias and pulmonary hypertension |
Pulmonary hypertension; the guidelines |
|
|
7258 |
ESC guidelines on ventricular arrhythmias and pulmonary hypertension |
ESC guidelines on pulmonary hypertension: implications for UK practice |
|
|
7807 |
ESC guidelines on ventricular arrhythmias and pulmonary hypertension |
ESC guidelines on ventricular arrhythmias and sudden death: implications for UK practice |
|
|
5548 |
Prediction and Prevention in Acute Coronary Syndromes |
Novel applications of troponins - biomarker of treatment efficacy and early rule out strategies |
|
|
5549 |
Prediction and Prevention in Acute Coronary Syndromes |
Stable/Unstable CHD Imaging: PET/CTCA/MRI |
|
|
5550 |
Prediction and Prevention in Acute Coronary Syndromes |
Treatment of ACS |
|
|
5552 |
Prediction and Prevention in Acute Coronary Syndromes |
Troponins in the diagnosis of MI: thresholds, sex and type1/type 2 |
|
|
7128 |
Kawasaki disease and its coronary consequences |
Service models for management in the UK |
|
|
7129 |
Kawasaki disease and its coronary consequences |
Diagnosis and aetiology |
|
|
7130 |
Kawasaki disease and its coronary consequences |
Prevention and treatment of coronary complications. |
|
|
7373 |
Cardiovascular-related maternal death; can we do better? |
Mechanical valves |
|
|
7374 |
Cardiovascular-related maternal death; can we do better? |
Aortopathy |
|
|
7375 |
Cardiovascular-related maternal death; can we do better? |
Heart failure |
|
|
7376 |
Cardiovascular-related maternal death; can we do better? |
Sudden death |
|
|
5571 |
How to investigate dilated cardiomyopathy |
Aetiology of acquired DCM |
|
|
5575 |
How to investigate dilated cardiomyopathy |
Who gets genetic testing and what genes are tested? |
|
|
5576 |
How to investigate dilated cardiomyopathy |
Imaging (Echo and MRI) |
|
|
7792 |
How to investigate dilated cardiomyopathy |
Role of biopsy and cardiac catheterisation |
|
|
7487 |
Hypertension 2016 |
Why cardiologists should be interested in hypertension |
|
|
7526 |
Hypertension 2016 |
Drugs and interventions for high blood pressure |
|
|
7528 |
Hypertension 2016 |
How to diagnose hypertension: rules and pitfalls |
|
|
7029 |
Hypertension 2016 |
How to investigate the hypertensive patient |
|
|
7013 |
Congenital left ventricular outflow tract obstruction |
The spectrum of left heart obstruction in Congenital Heart Disease |
|
|
7020 |
Congenital left ventricular outflow tract obstruction |
Management Options in Congenital LVOTO - Surgery |
|
|
7420 |
Congenital left ventricular outflow tract obstruction |
Management Options in Congenital LVOTO - Intervention |
|
|